February 18, 2016
JCR Pharmaceuticals will launch Temcell HS Injection, a cell therapy for a post-transplant complication, on February 24, with the product to be solely distributed by major wholesaler Medipal Holdings via an ultra-low cold delivery system. Temcell, approved in September as...read more